Skip to main content
NIH funding notice PAR-18-319

HIV Vaccine Research and Design (HIVRAD) Program (P01 Clinical Trial Not Allowed)

Closed on March 13, 2020.

Posted
October 13, 2017
Close date
March 13, 2020
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

Read the notice on Grants.gov · NIH Guide page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

6 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $13,258,571 in first-year total cost, median $2,176,440.

Most frequent study sections

  1. Special Emphasis Panel[ZAI1 JRR-A (S1)]3
  2. Special Emphasis Panel[ZAI1 KKS-A (S1)]2
  3. Special Emphasis Panel[ZAI1 CD-A (S4)]1

Most frequent institutions

  1. DUKE UNIVERSITY2
  2. CALIFORNIA INSTITUTE OF TECHNOLOGY1
  3. FRED HUTCHINSON CANCER RESEARCH CENTER1
  4. SCRIPPS RESEARCH INSTITUTE, THE1
  5. WEILL MEDICAL COLL OF CORNELL UNIV1
Competing awards under PAR-18-319 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
2021Eliciting neutralizing antibodies and B cell responses using novel HIV Env immunogens in non-human primates1P01AI157299-01WYATT, RICHARD THOMASSCRIPPS RESEARCH INSTITUTE, THE, CA$3,242,006ZAI1
2020Cleaved, stabilized HIV-1 Env trimers for structural and vaccine studies2P01AI110657-06MOORE, JOHN PWEILL MEDICAL COLL OF CORNELL UNIV, NY$3,108,766ZAI1
2020Early Life Vaccination to Prevent HIV acquisition during Adolescence2P01AI117915-06DE PARIS, KRISTINAPERMAR, SALLIE R.DUKE UNIVERSITY, NC$1,307,799ZAI1
2019Developing Immunogens to Elicit Broadly Neutralizing anti-HIV-1 Antibodies2P01AI100148-06A1BJORKMAN, PAMELA JNUSSENZWEIG, MICHEL CCALIFORNIA INSTITUTE OF TECHNOLOGY, CA$2,561,973ZAI1
2019Expansion and targeted maturation of germline HIV-1 bNAb-associated BCRs1P01AI138212-01A1STAMATATOS, LEONIDASFRED HUTCHINSON CANCER RESEARCH CENTER, WA$1,790,906ZAI1
2019Immunogen Design for Induction of HIV distal gp41 broadly neutralizing antibodies1P01AI138211-01A1ALAM, S. MUNIRDUKE UNIVERSITY, NC$1,247,121ZAI1

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.

PAR-18-319: HIV Vaccine Research and Design (HIVRAD) Program (P01 Clinical Trial Not Allowed) | ScienceDex | ConductScience